Hot Research Topic: Tumor Microenvironment (TME) and the Core Role of Multiplex Fluorescence Labeling Technology

1. Concept: What is Tumor Microenvironment (TME)?

The microenvironment surrounding normal human tissues serves as a crucial barrier for the body to defend against tumors, effectively inhibiting tumor growth. However, tumor cells implanted in normal tissues can alter the microenvironment around them by recruiting cancer-associated fibroblasts (CAFs), regulating immune cells and their secreted factors, and promoting the formation of new blood vessels by vascular endothelial cells, thereby forming the Tumor Microenvironment (TME). TME is a complex and dynamic ecosystem that is closely intertwined with tumor progression, immune escape, and therapeutic response.

2. Research Frontiers

Currently, research on the inhibitory mechanisms of TME has become increasingly prominent in the field of oncology, with a particular focus on the cellular and stromal components of TME. Key research directions include exploring the regulatory mechanisms of immunosuppressive cells (such as regulatory T cells, tumor-associated macrophages, and myeloid-derived suppressor cells) in TME, clarifying the role of stromal components represented by CAFs in tumor progression, and investigating the complex network of soluble factors in TME. Additionally, the development of precise in situ labeling technologies for multiple immune cell subsets has become a core focus of TME research, as it is essential for deciphering the interactions between various cell populations and stromal factors.

3. Research Significance

In-depth exploration of TME holds profound significance for advancing tumor research and clinical treatment. TME plays a dual role in tumor development: in the early stage of tumor growth, it can form an anti-tumor inflammatory microenvironment; however, with tumor progression, it transforms into a comprehensive immunosuppressive TME. This immunosuppressive TME promotes tumor immune escape, enhances malignancy and invasiveness, and antagonizes therapeutic effects, thereby affecting tumor occurrence, development, and drug resistance. Understanding the formation mechanism and regulatory network of TME provides new targets for the development of anti-tumor therapies, such as immunotherapy targeting immune checkpoints, targeted therapy against CAFs, and strategies to remodel the immunosuppressive TME.

4. Related Mechanisms and Research Methods/Product Applications

4.1 Mechanisms of Immunosuppressive TME Formation

4.1.1 Changes in Stromal Components

Fibroblasts in normal tissues play important roles in maintaining the stability of tissue structure, repairing tissue damage, and inhibiting tumor formation. During the formation and evolution of TME, normal fibroblasts are transformed into cancer-associated fibroblasts (CAFs)—a key component of stromal components—under the stimulation of various chemokines. Fibroblast activation protein α (FAPα), a specific marker on the surface of CAFs, can enhance the directional invasive ability of tumor cells along fibers, participate in tumor angiogenesis, form a tumor biological barrier, and inhibit the function of effector T cells by promoting stromal remodeling and participating in signal transduction such as vascular endothelial growth factor (VEGF), thereby promoting tumor progression.

4.1.2 Changes in Cellular Components

Tumor cells can inhibit the response and function of infiltrating immune cells and induce immune escape through multiple pathways, such as inhibiting signaling pathways like PD-1/PD-L1 and secreting inhibitory factors such as interleukin 2 (IL-2) and IL-10. In addition, the metabolic reprogramming of tumor cells consumes excessive glucose and amino acids, competitively depriving T cells of necessary nutrients, which also promotes T cell dysfunction and immunosuppression. On the other hand, the recruitment and expansion of immunosuppressive cells in TME—such as regulatory T cells (Tregs), tumor-associated macrophages (TAMs), and myeloid-derived suppressor cells (MDSCs)—are also one of the main mechanisms inducing immunosuppressive TME.

4.1.3 Changes in Soluble Factors

A large number of soluble immunosuppressive factors in TME are also important mechanisms for tumors to escape immune surveillance. Soluble factors such as TGF-β, VEGF, chemokines, and inflammatory cytokines undergo dynamic changes and interactions, forming a complex network. They collectively induce functional changes in immune cells and tumor cells, participate in inducing angiogenesis and interstitial fibrosis in TME, promote the formation of immunosuppressive TME, and thus lead to malignant proliferation, invasion, and metastasis of tumors.

4.2 Core Research Method: Multiplex Fluorescence Labeling Technology

The precise in situ labeling of multiple immune cell subsets is a key focus of current TME research. Multiplex fluorescence labeling technology, which enables simultaneous labeling of multiple indicators on a single slide, greatly improves the information content of single-slide staining. It plays a crucial role in studying the interaction between various cell populations and the interaction between stromal factors. ANT BIO PTE. LTD. provides high-quality multiplex fluorescence immunohistochemistry (mIHC) solutions through its Absin product line, including multiplex fluorescence IHC staining kits and specific antibodies, covering the entire process from staining and imaging to analysis. These solutions can achieve simultaneous labeling of up to 6 indicators, and also provide quantitative analysis and spatial analysis services, effectively supporting in-depth TME research.

4.3 Typical Application: Co-staining of CD4, PD-1, CD19, and CD8

In TME research, the co-staining of immune cell markers such as CD4, PD-1, CD19, and CD8 is a common and important application. Using ANT BIO PTE. LTD.'s multiplex fluorescence IHC staining kits, researchers can simultaneously detect the spatial distribution and expression levels of these markers in tumor tissues, thereby clarifying the infiltration status of different immune cell subsets and their functional states (such as PD-1 expression indicating T cell exhaustion). This information is crucial for evaluating the immunosuppressive status of TME and guiding the development of immunotherapeutic strategies.

5. Brand Mission

ANT BIO PTE. LTD. is dedicated to empowering life science research through the provision of high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) are strategically positioned to cover a full spectrum of research needs: Absin focuses on general reagents and kits, Starter specializes in antibodies, and UA is dedicated to recombinant proteins. We strive to support researchers in unlocking scientific mysteries, advancing medical progress, and addressing unmet clinical needs through continuous innovation and customer-centric services.

6. Related Product List

7. Disclaimer

This article is AI-compiled and interpreted based on the original work in DOI: 10.1002/advs.202413562. All intellectual property (e.g., images, data) of the original publication shall belong to the journal and the research team. For any infringement, please contact us promptly and we will take immediate action.

8. Brand Promotion Copy

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.